Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-02-01 @ 6:15 PM
Study NCT ID:
NCT03111992
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2017-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-22
First Submit QC Date:
None
Study First Post Date:
2017-04-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-07
Last Update Post Date:
2022-02-09
Last Update Post Date Type:
ACTUAL